Epidermal Growth Factor Receptor Activating Mutations in Squamous Histology of Lung Cancer Patients of Southern Bulgaria
There is only limited data on the prevalence of epidermal growth factor receptor (EGFR) activating mutations in squamous cell carcinomas and adenosquamous carcinomas of the lung in patients of the Southern Bulgarian region and the efficacy of EGFR tyrosine kinase inhibitors. AIM: Previous reports fo...
Main Authors: | Genova Silvia N., Bichev Stoian N., Kanarev Vladimir G. |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2015-12-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0038/folmed-2015-0038.xml?format=INT |
Similar Items
-
The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
by: Hsiang-Ling Ho, et al.
Published: (2019-06-01) -
Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma
by: Zhang C, et al.
Published: (2018-08-01) -
Metaplastic Squamous Cell Carcinoma of Breast-An Uncommon Tumor with an Unusual Presentation A Case Report
by: Javeria Faridi , Saeed Alam
Published: (2021-12-01) -
Adenosquamous Carcinoma and Pure Squamous Cell Carcinoma of the Pancreas: Report of two Cases
by: Tadashi Terada
Published: (2010-09-01) -
Adenoid Squamous Cell Carcinoma of Oral Cavity: a Case Report
by: Chandrakala Jayani, et al.
Published: (2018-03-01)